
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.550 | 2.860 | 0.310 |
Shares | 69.270 | 69.270 | 0.000 |
Bonds | 25.440 | 25.440 | 0.000 |
Convertible | 1.550 | 1.550 | 0.000 |
Preferred | 0.540 | 0.540 | 0.000 |
Other | 0.650 | 0.650 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.549 | 18.192 |
Price to Book | 2.165 | 2.966 |
Price to Sales | 1.554 | 2.123 |
Price to Cash Flow | 10.135 | 11.562 |
Dividend Yield | 2.433 | 2.126 |
5 Years Earnings Growth | 9.555 | 9.886 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 22.880 | 20.414 |
Technology | 16.770 | 18.728 |
Industrials | 14.240 | 13.065 |
Consumer Defensive | 9.740 | 7.704 |
Healthcare | 8.580 | 10.280 |
Consumer Cyclical | 8.560 | 10.679 |
Communication Services | 7.600 | 6.362 |
Energy | 6.870 | 5.978 |
Basic Materials | 4.630 | 5.396 |
Utilities | 0.130 | 2.631 |
Number of long holdings: 4
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Manulife Global Dividend Adv | - | 50.53 | - | - | |
Manulife Fundamental Equity Adv | - | 20.42 | - | - | |
Manulife Corporate Bond Adv | - | 14.56 | - | - | |
Manulife Strategic Income Adv | - | 14.51 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Div incm Sel InvPlus | 1.06B | 2.44 | 9.37 | 8.35 | ||
Manulife Dividend Income Seg Fund C | 1.06B | 2.03 | 8.53 | 7.47 | ||
Manulife Div incm Sel Org 75 Elite | 1.06B | 3.09 | 10.77 | 9.54 | ||
Manulife Dividend Income Seg RESP | 1.06B | 2.39 | 9.29 | 8.27 | ||
Manulife Div incm Sel InvPlus E | 1.06B | 2.99 | 10.56 | 9.53 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review